Delivery Order SPE2DB24D9131-SPE2DB25FXRT1
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,234.25 for Botox 200-unit vials by the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and carries no set-aside designation. This award represents a discrete order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,775.42 by the Defense Logistics Agency on August 28, 2025, for the supply of Botox 100 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 19, 2025, and was executed with no set-aside designation. Performance will occur at the contractor's facility in Park Ridge, Illinois. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $3,881.10. The award was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, leveraging DMS Pharmaceutical Group's established position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Botox 200-unit vials with a ceiling value of $3,881.10. This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on July 22, 2025, for the supply of Botox 100 Unit Vials. The contract utilizes a firm fixed-price delivery model with an ultimate completion date of August 12, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $45,905 delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of May 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA valued at $500 million...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.4K by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Botox 200 unit vials. The delivery order carries an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 200-unit vials of Botox, with a contract ceiling value of $9,702.75. The award, issued on September 18, 2025, carries an ultimate completion date of October 9, 2025, and utilizes firm fixed-price pricing. This delivery order is issued without a set-aside designation and represents performance work to be...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $11,564.25 for Botox 100-unit vials by the Defense Logistics Agency's Medical Supply Chain division. The firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, carries no set-aside designation. This award falls under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Botox 100 unit vials. This firm fixed-price delivery order, valued at $11,101.68, is scheduled for completion by September 18, 2025, and represents performance to be delivered at the contractor's Park Ridge, Illinois location. The award was made without a set-aside designation,...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRT1Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,700.56 by the Defense Logistics Agency (DLA) for the supply of Botox 100 unit vials. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, was issued without a set-aside designation. The contract is performed at the contractor's facility in Park Ridge, Illinois, and represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499.999 billion and valid through November 2026. Under this overarching SPE2DB program vehicle, the DLA issues firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting the medical supply needs of military health facilities worldwide. The Botox procurement exemplifies the company's portfolio of specialty pharmaceutical deliveries, which encompasses branded and generic prescription drugs, biologics, medical consumables, and specialty medications spanning various therapeutic categories to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/14/25 |